Description

The SLU-PP-332 + SS-31 + MOTS-c Combination Protocol is designed to deliver comprehensive support to the body’s mitochondrial, metabolic, and cellular energy systems — the core drivers of aging, performance, and tissue regeneration.

SLU-PP-332 is a metabolic signaling peptide studied for its ability to activate PPAR-delta pathways, which play a central role in fat oxidation, endurance, and mitochondrial biogenesis. It has gained significant research interest for its potential to mimic aspects of exercise-induced metabolic adaptation and improve energy utilization at the cellular level.

SS-31 (also known as Elamipretide) is a mitochondria-targeting peptide that selectively binds to cardiolipin within the inner mitochondrial membrane. This helps stabilize mitochondrial structure, reduce oxidative stress, and improve ATP production. SS-31 is widely researched for its role in mitochondrial repair, cellular longevity, and tissue recovery.

MOTS-c is a mitochondrial-derived peptide that regulates glucose metabolism, insulin sensitivity, and metabolic resilience. It functions as a signaling molecule between mitochondria and the nucleus, helping coordinate cellular energy use and stress response.

When combined, these three peptides form a synergistic mitochondrial optimization protocol that supports:

• Cellular energy production (ATP)

• Fat oxidation and metabolic efficiency

• Oxidative stress reduction

• Mitochondrial biogenesis

• Tissue vitality and rejuvenation

• Endurance and recovery pathways

This protocol is often referred to as a “mitochondrial glow and performance stack” because it addresses the root drivers of skin quality, hair, metabolic health, and cellular youthfulness.

---

Why These Peptides Are Supplied in Separate Vials

Although SLU-PP-332, SS-31, and MOTS-c are designed to work together in a single protocol, they are never mixed in the same vial.

Each peptide has a distinct molecular structure, stability profile, and pH tolerance. When peptides are combined in solution, they may:

• Degrade more rapidly

• Lose biological activity

• Interact chemically

• Form unstable peptide complexes

To ensure maximum potency, stability, and pharmaceutical-grade purity, NordisPharma supplies each peptide in its own sterile vial. This preserves:

• Molecular integrity

• Accurate dosing

• Shelf life

• Research reliability

They are intended to be used together as a coordinated protocol, but stored separately for optimal performance.

The SLU-PP-332 + SS-31 + MOTS-c Combination Protocol is designed to deliver comprehensive support to the body’s mitochondrial, metabolic, and cellular energy systems — the core drivers of aging, performance, and tissue regeneration.

SLU-PP-332 is a metabolic signaling peptide studied for its ability to activate PPAR-delta pathways, which play a central role in fat oxidation, endurance, and mitochondrial biogenesis. It has gained significant research interest for its potential to mimic aspects of exercise-induced metabolic adaptation and improve energy utilization at the cellular level.

SS-31 (also known as Elamipretide) is a mitochondria-targeting peptide that selectively binds to cardiolipin within the inner mitochondrial membrane. This helps stabilize mitochondrial structure, reduce oxidative stress, and improve ATP production. SS-31 is widely researched for its role in mitochondrial repair, cellular longevity, and tissue recovery.

MOTS-c is a mitochondrial-derived peptide that regulates glucose metabolism, insulin sensitivity, and metabolic resilience. It functions as a signaling molecule between mitochondria and the nucleus, helping coordinate cellular energy use and stress response.

When combined, these three peptides form a synergistic mitochondrial optimization protocol that supports:

• Cellular energy production (ATP)

• Fat oxidation and metabolic efficiency

• Oxidative stress reduction

• Mitochondrial biogenesis

• Tissue vitality and rejuvenation

• Endurance and recovery pathways

This protocol is often referred to as a “mitochondrial glow and performance stack” because it addresses the root drivers of skin quality, hair, metabolic health, and cellular youthfulness.

---

Why These Peptides Are Supplied in Separate Vials

Although SLU-PP-332, SS-31, and MOTS-c are designed to work together in a single protocol, they are never mixed in the same vial.

Each peptide has a distinct molecular structure, stability profile, and pH tolerance. When peptides are combined in solution, they may:

• Degrade more rapidly

• Lose biological activity

• Interact chemically

• Form unstable peptide complexes

To ensure maximum potency, stability, and pharmaceutical-grade purity, NordisPharma supplies each peptide in its own sterile vial. This preserves:

• Molecular integrity

• Accurate dosing

• Shelf life

• Research reliability

They are intended to be used together as a coordinated protocol, but stored separately for optimal performance.